150 related articles for article (PubMed ID: 10364203)
21. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
22. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
[TBL] [Abstract][Full Text] [Related]
23. Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.
Russell PL; Sharom FJ
Biochem J; 2006 Oct; 399(2):315-23. PubMed ID: 16803457
[TBL] [Abstract][Full Text] [Related]
24. Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.
Julien M; Gros P
Biochemistry; 2000 Apr; 39(15):4559-68. PubMed ID: 10758006
[TBL] [Abstract][Full Text] [Related]
25. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
Toffoli G; Simone F; Gigante M; Boiocchi M
Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
[TBL] [Abstract][Full Text] [Related]
26. The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.
Romsicki Y; Sharom FJ
Eur J Biochem; 1998 Aug; 256(1):170-8. PubMed ID: 9746361
[TBL] [Abstract][Full Text] [Related]
27. Selection and characterization of verapamil-resistant multidrug resistant cells.
Cano-Gauci DF; Seibert FS; Safa AR; Riordan JR
Biochem Biophys Res Commun; 1995 Apr; 209(2):497-505. PubMed ID: 7733917
[TBL] [Abstract][Full Text] [Related]
28. Equilibrium, kinetic and photoaffinity labeling studies of daunomycin binding to P-glycoprotein-containing membranes of multidrug-resistant Chinese hamster ovary cells.
Busche R; Tümmler B; Cano-Gauci DF; Riordan JR
Eur J Biochem; 1989 Jul; 183(1):189-97. PubMed ID: 2568928
[TBL] [Abstract][Full Text] [Related]
29. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
30. Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies.
Sharom FJ; Liu R; Romsicki Y; Lu P
Biochim Biophys Acta; 1999 Dec; 1461(2):327-45. PubMed ID: 10581365
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.
Wallstab A; Koester M; Böhme M; Keppler D
Br J Cancer; 1999 Mar; 79(7-8):1053-60. PubMed ID: 10098736
[TBL] [Abstract][Full Text] [Related]
32. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
[TBL] [Abstract][Full Text] [Related]
33. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.
Park S; Majd S
PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971
[TBL] [Abstract][Full Text] [Related]
34. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
[TBL] [Abstract][Full Text] [Related]
35. A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
Michieli M; Michelutti A; Damiani D; Pipan C; Raspadori D; Lauria F; Baccarani M
Leuk Lymphoma; 1993 Feb; 9(3):255-64. PubMed ID: 8097129
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding.
Rosenberg MF; Kamis AB; Callaghan R; Higgins CF; Ford RC
J Biol Chem; 2003 Mar; 278(10):8294-9. PubMed ID: 12501241
[TBL] [Abstract][Full Text] [Related]
37. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein.
Al-Shawi MK; Polar MK; Omote H; Figler RA
J Biol Chem; 2003 Dec; 278(52):52629-40. PubMed ID: 14551217
[TBL] [Abstract][Full Text] [Related]
38. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
Germann UA; Shlyakhter D; Mason VS; Zelle RE; Duffy JP; Galullo V; Armistead DM; Saunders JO; Boger J; Harding MW
Anticancer Drugs; 1997 Feb; 8(2):125-40. PubMed ID: 9073309
[TBL] [Abstract][Full Text] [Related]
39. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.
Ambudkar SV; Lelong IH; Zhang J; Cardarelli CO; Gottesman MM; Pastan I
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8472-6. PubMed ID: 1356264
[TBL] [Abstract][Full Text] [Related]
40. B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance.
Boumendjel A; Bois F; Beney C; Mariotte AM; Conseil G; Di Pietro A
Bioorg Med Chem Lett; 2001 Jan; 11(1):75-7. PubMed ID: 11140738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
